MET overexpression and intratumor heterogeneity in esophageal squamous cell carcinoma
Braz. j. med. biol. res; 54 (8), 2021
Esophageal squamous cell carcinoma (ESCC) is among the ten most frequent and deadly cancers, without effective therapies for most patients. More recently, drugs targeting deregulated growth factor signaling receptors have been developed, such as HGF-MET targeted therapy. We assessed MET and HGF genetic a...
Brasil, Carcinoma de Células Escamosas/genética, Línea Celular Tumoral, Neoplasias Esofágicas/genética, Carcinoma de Células Escamosas de Esófago/genética, Regulación Neoplásica de la Expresión Génica, Neoplasias de Cabeza y Cuello, Proteínas Proto-Oncogénicas c-met/genética, Proteínas Proto-Oncogénicas c-met/metabolismo